Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Huayang Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise located in Jurong, Jiangsu Province, China. The company focuses on the development, production, and sale of chemical active pharmaceutical ingredients (APIs) and finished drug products, including tablets, capsules, and granules. Its portfolio primarily targets chronic conditions such as hypertension and diabetes, as well as infectious diseases and gastrointestinal disorders. Operating under strict GMP standards, Jiangsu Huayang has established a significant presence in the Chinese domestic market while expanding its export business. The firm is known for its integrated manufacturing chain, which ensures quality control from raw material synthesis to final dosage forms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Huayang Pharmaceutical.